Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment opens in phase III trial of STR in multiple myeloma

April 1, 2004

YM BioSciences to commence pivotal tesmilifene trial in coming weeks

April 1, 2004

NAD-299, RS-23597 active in prostate cancer cells

April 1, 2004

Atrasentan delays disease progression in metastatic prostate cancer

April 1, 2004

ECO-04601 demonstrates broad antitumor activity in various tumor cell lines

March 31, 2004

RGB-286199, a potent, broad-spectrum cyclin-dependent kinase inhibitor

March 31, 2004

Doxazosin reduces bladder cancer tumor growth in vivo

March 31, 2004

Enhancement of paclitaxel anticancer activity with HSP70 inducer STA-4783

March 31, 2004

Nereus presents data on NPI-0052, a novel, oral proteasome inhibitor

March 31, 2004

Potent cytotoxic nucleoside for HCC therapy

March 31, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...